Shinpoong Pharmaceutical Co (XKRX:019170) Buildings And Improvements : ₩118,504 Mil (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Shinpoong Pharmaceutical Co Buildings And Improvements?

Shinpoong Pharmaceutical Co's quarterly buildings and improvements declined from Sep. 2023 (₩123,306 Mil) to Dec. 2023 (₩117,283 Mil) but then increased from Dec. 2023 (₩117,283 Mil) to Mar. 2024 (₩118,504 Mil).

Shinpoong Pharmaceutical Co's annual buildings and improvements declined from Dec. 2021 (₩119,389 Mil) to Dec. 2022 (₩118,150 Mil) and declined from Dec. 2022 (₩118,150 Mil) to Dec. 2023 (₩117,283 Mil).

Shinpoong Pharmaceutical Co Buildings And Improvements Historical Data

The historical data trend for Shinpoong Pharmaceutical Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shinpoong Pharmaceutical Co Buildings And Improvements Chart

Shinpoong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

116,738.35

116,931.90

119,389.20

118,150.45

117,282.63

Shinpoong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															118,439.65	118,619.39	123,306.42	117,282.63	118,503.96

Shinpoong Pharmaceutical Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Shinpoong Pharmaceutical Co (XKRX:019170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019170) » Definitions » Buildings And Improvements

Traded in Other Exchanges

019175:Korea

Address

161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246

Website

https://shinpoong.co.kr

Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.

Shinpoong Pharmaceutical Co (XKRX:019170) Headlines

No Headlines